Monday, March 1, 2021

કોરોના વેકસીન માટે સામાન્ય લોકો માટે રજીસ્ટ્રેશન પ્રોસેસ માહિતી

New cases of coronavirus in India have once again reached over 15,000. In the last 24 hours, about 16,500 new cases have been revealed. According to the latest data released on Saturday by the Health Ministry, the total number of infections in the country has increased to 1,10,79,979 with 16,488 new cases coming in the last 24 hours. At the same time, 113

patients have died due to the virus in the last 24 hours a day. So far, about 1.57 lakh people have lost their lives in the country.

Today, for the third consecutive day, more than 16,000 new cases of corona have been registered. 16,488 new cases were registered on Saturday, 16,577 new COVID-19 cases on Friday and 16,738 new cases in 24 hours on Thursday.Prime Minister Narendra Modi has administered the first dose of corona virus vaccine at AIIMS Hospital in the capital today. PM Modi reached AIIMS at around 6 in the morning and got the first dose of Corona vaccine installed there.

According to Health Ministry data, 12,771 patients have recovered in the last 24 hours. So far, 1.07 crore patients in India have been able to beat the virus. The recovery rate from Corona has come down to 97.14 percent. On a daily basis, the number of active cases has increased due to less number of patients recovering daily as compared to new cases. The number of active cases of corona in the country has increased to 1.59 lakh. 

રજીસ્ટ્રેશન પ્રોસેસ વેબસાઇટ 


ગુજરાતીમાં માહિતી -પ્રોસેસ 


તમારા જિલ્લાનું હોસ્પિટલ લિસ્ટ 


ગાઈડલાઇન ડાઉનલોડ 

Active patients are 1.44 percent.The entire cost of vaccination at the government vaccine center will be borne by the central government. Free vaccination will be done at these centers. The maximum cost of vaccine will be Rs 250 at the Kovid Vaccine Center in private hospitals in the states. To facilitate the effective use of CoWIN 2.0, private facilities can also be given usernames and passwords. Kovin app and Arogya Setu can also be used for registration.

Prior to COVID‑19, a vaccine for an infectious disease had never been produced in less than several years—and no vaccine existed for preventing a coronavirus infection in humans.[8] However, vaccines have been produced against several animal diseases caused by coronaviruses, including (as of 2003) infectious bronchitis virus in birds, canine coronavirus, and feline coronavirus.[9] Previous projects to develop vaccines for viruses in the family Coronaviridae that affect humans have been aimed at severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Vaccines against SARS[10] and MERS[11] have been tested in non-human animals. According to studies published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around the world at that time.[12][13][14] As of 2020, there is no cure or protective vaccine proven to be safe and effective against SARS in humans.[15][16] There is also no proven vaccine against MERS.[17] When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.[15][18] As of March 2020, there was one (DNA based) MERS vaccine which completed Phase I clinical trials in humans[19] and three others in progress, all being viral-vectored vaccines: two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) and one MVA-vectored (MVA-MERS-S).[20]

Share This
Previous Post
Next Post

Pellentesque vitae lectus in mauris sollicitudin ornare sit amet eget ligula. Donec pharetra, arcu eu consectetur semper, est nulla sodales risus, vel efficitur orci justo quis tellus. Phasellus sit amet est pharetra